Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
  2. Wang, Hua; Cheng, Cheng; Dal Santo, James L; Shen, Chen-Hsiang; Bylund, Tatsiana; Henry, Amy R; Howe, Colin A; Hwang, Juyun; Morano, Nicholas C; Morris, Daniel J; Pletnev, Sergei; Roark, Ryan S; Zhou, Tongqing; Hansen, Bryan T; Hoyt, Forrest H; Johnston, Timothy S; Wang, Shuyi; Zhang, Baoshan; Ambrozak, David R; Becker, Jordan E; Bender, Michael F; Changela, Anita; Chaudhary, Ridhi; Corcoran, Martin; Corrigan, Angela R; Foulds, Kathryn E; Guo, Yicheng; Lee, Myungjin; Li, Yingying; Lin, Bob C; Liu, Tracy; Louder, Mark K; Mandolesi, Marco; Mason, Rosemarie D; McKee, Krisha; Nair, Vinod; O'Dell, Sijy; Olia, Adam S; Ou, Li; Pegu, Amarendra; Raju, Nagarajan; Rawi, Reda; Roberts-Torres, Jesmine; Sarfo, Edward K; Sastry, Mallika; Schaub, Andrew J; Schmidt, Stephen D; Schramm, Chaim A; Schwartz, Cindi L; Smith, Sarah C; Stephens,Tyler; Stuckey, Jonathan; Teng, I-Ting; Todd, John-Paul; Tsybovsky,Yaroslav; Van Wazer, David J; Wang, Shuishu; Doria-Rose, Nicole A; Fischer, Elizabeth R; Georgiev, Ivelin S; Karlsson Hedestam, Gunilla B; Sheng, Zizhang; Woodward, Ruth A; Douek, Daniel C; Koup, Richard A; Pierson, Theodore C; Shapiro, Lawrence; Shaw, George M; Mascola, John R; Kwong, Peter D
  3. Cell. 2024, Oct 23;
  1. 2.   SMAC mimetic plus triple combination bispecific HIVxCD3 DART® molecules in SHIV.C.CH505-infected, ART-suppressed rhesus macaques
  2. Dashti, Amir; Waller, Chevaughn; Mavigner, Maud; Schoof, Nils; Bar, Katharine J; Shaw, George M; Vanderford, Thomas; Liang, Shan; Lifson,Jeffrey; Dunham, Richard M; Ferrari, Guido; Tuyishime, Marina; Lam, Chia-Ying K; Nordstrom, Jeffrey L; Margolis, David M; Silvestri, Guido; Chahroudi, Ann
  3. Journal of virology. 2020, NOV; 94(21): pii: JVI.00793-20..
  1. 3.   The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
  2. Bender, Alexandra M; Simonetti, Francesco R; Kumar, Mithra R; Fray, Emily J; Bruner, Katherine M; Timmons, Andrew E; Tai, Katherine Y; Jenike, Katharine M; Antar, Annukka A R; Liu, Po-Ting; Ho, Ya-Chi; Raugi, Dana N; Seydi, Moussa; Gottlieb, Geoffrey S; Okoye, Afam A; Del Prete,Greg; Picker, Louis J; Mankowski, Joseph L; Lifson,Jeffrey; Siliciano, Janet D; Laird, Greg M; Barouch, Dan H; Clements, Janice E; Siliciano, Robert F
  3. Cell host & microbe. 2019, Jul 10; 26(1): 73-85.e4.
  1. 4.   Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
  2. Martinez-Navio, José M; Fuchs, Sebastian P; Pantry, Shara N; Lauer, William A; Duggan, Natasha N; Keele, Brandon; Rakasz, Eva G; Gao, Guangping; Lifson, Jeffrey; Desrosiers, Ronald C
  3. Immunity. 2019, Mar 19; 50(3): 567-+.
  1. 5.   Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
  2. Munson, Paul; Liu, Yi; Bratt, Debra; Fuller, James T; Hu, Xintao; Pavlakis, George; Felber, Barbara; Mullins, James I; Fuller, Deborah Heydenburg
  3. Human vaccines & immunotherapeutics. 2018, Apr 12; 14(7): 1820-1831.
  1. 6.   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  2. Denton, P. W.; Othieno, F.; Martinez-Torres, F.; Zou, W.; Krisko, J. F.; Fleming, E.; Zein, S.; Powell, D. A.; Wahl, A.; Kwak, Y. T.; Welch, B. D.; Kay, M. S.; Payne, D. A.; Gallay, P.; Appella, E.; Estes, J. D.; Lu, M.; Garcia, J. V.
  3. Journal of Virology. 2011, Aug; 85(15): 7582-7593.
  1. 7.   Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice
  2. Denton, P. W.; Krisko, J. F.; Powell, D. A.; Mathias, M.; Kwak, Y. T.; Martinez-Torres, F.; Zou, W.; Payne, D. A.; Estes, J. D.; Garcia, J. V.
  3. Plos One. 2010, Jan; 5(1): 11.
  1. 8.   Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges
  2. Ambrose, Z.; Compton, L.; Piatak, M.; Lu, D.; Alvord, W. G.; Lubomirski, M. S.; Hildreth, J.; Lifson, J. D.; Miller, C. J.; KewalRamani, V. N.
  3. Journal of Virology. 2008 82(13): 6591-6599.
  1. 9.   Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid
  2. Boyer, J. D.; Robinson, T. M.; Kutzler, M. A.; Vansant, G.; Hokey, D. A.; Kumar, S.; Parkinson, R.; Wu, L.; Sidhu, M. K.; Pavlakis, G. N.; Felber, B. K.; Brown, C.; Silvera, P.; Lewis, M. G.; Monforte, J.; Waldmann, T. A.; Eldridge, J.; Weiner, D. B.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Nov; 104(47): 18648-18653.
  1. 10.   Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
  2. Earl, P. L.; Americo, J. L.; Wyatt, L. S.; Eller, L. A.; Montefiori, D. C.; Byrum, R.; Piatak, M.; Lifson, J. D.; Amara, R. R.; Robinson, H. L.; Huggins, J. W.; Moss, B.
  3. Virology. 2007, Sep; 366(1): 84-97.
  1. 11.   Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses
  2. Robinson, T. M.; Sidhui, M. K.; Pavlakis, G. N.; Felber, B. K.; Silvera, P.; Lewis, M. G.; Eldridge, J.; Weiner, D. B.; Boyer, J. D.
  3. Journal of Medical Primatology. 2007, Aug; 36(4-5): 276-284.
  1. 12.   Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques
  2. Chong, S. Y.; Egan, M. A.; Kutzler, M. A.; Megati, S.; Masood, A.; Roopchard, V.; Garcia-H, D.; Montefiori, D. C.; Quiroz, J.; Rosati, M.; Schadeck, E. B.; Boyer, J. D.; Pavlakis, G. N.; Weiner, D. B.; Sidhu, M.; Eldridge, J. H.; Israel, Z. R.
  3. Vaccine. 2007, Jun; 25(26): 4967-4982.
  1. 13.   Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques
  2. Gomez-Roman, V. R.; Grimes, G. J.; Potti, G. K.; Peng, B.; Demberg, T.; Gravlin, L.; Treece, J.; Pal, R.; Lee, E. M.; Alvord, W. G.; Markham, P. D.; Robert-Guroff, M.
  3. Vaccine. 2006, Jun; 24(23): 5064-5072.
  1. 14.   In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques
  2. Ambrose, Z.; Boltz, V.; Palmer, S.; Coffin, J. M.; Hughes, S. H.; KewalRamani, V. N.
  3. Journal of Virology. 2004, DEC; 78(24): 13553-13561.
  1. 15.   Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5
  2. Lederman, M. M.; Veazey, R. S.; Offord, R.; Mosier, D. E.; Dufour, J.; Mefford, M.; Piatak, M.; Lifson, J. D.; Salkowitz, J. R.; Rodriguez, B.; Blauvelt, A.; Hartley, O.
  3. Science. 2004, OCT 15; 306(5695): 485-487.
  1. 16.   An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
  2. Wang, S. W.; Bertley, F. M. N.; Kozlowski, P. A.; Herrmann, L.; Manson, K.; Mazzara, G.; Piatak, M.; Johnson, R. P.; Carville, A.; Mansfield, K.; Aldovini, A.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 846-859.
  1. 17.   Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models
  2. Tsai, C. C.; Emau, P.; Jiang, Y. H.; Agy, M. B.; Shattock, R. J.; Schmidt, A.; Morton, W. R.; Gustafson, K. R.; Boyd, M. R.
  3. Aids Research and Human Retroviruses. 2004 20(1): 11-18.
  1. 18.   Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6
  2. Ambrose, Z.; Thompson, J.; Larsen, K.; Kuller, L.; Panicali, D. L.; Clements, J. D.; Agy, M.; Montefiori, D. C.; Hu, S. L.; Bosch, M. L.
  3. Virology. 2003 308(1): 178-190.
  1. 19.   Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques
  2. Patterson, L. J.; Peng, B.; Abimiku, A. G.; Aldrich, K.; Murty, L.; Markham, P. D.; Kalyanaraman, V. S.; Alvord, W. G.; Tartaglia, J.; Franchini, G.; Robert-Guroff, M.
  3. Aids. 2000 14(16): 2445-2455.
  1. 20.   Telomere dynamics in monkeys: Increased cell turnover in macaques infected with chimeric simian-human immunodeficiency viruses
  2. Shibata, R.; Feng, Y. R.; Gee, D.; Norwood, D.; Xiao, X. D.; Zeichner, S. L.; Martin, M. A.; Dimitrov, D. S.
  3. Journal of Medical Primatology. 1999 28(1): 1-10.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel